Sign in

Microbiotica

€42M · October 2026 · Microbiology & synthetic biology · Europe

What it sells

Develops precision microbiome medicines: defined live biotherapeutic products with known mechanisms of action, focused on immuno-oncology and inflammatory bowel disease.

Funding history and coverage

Round dateStageAmountInvestorsSource
2026-10-16—€42M—eu-startups.com

Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.

More startups in Microbiology & synthetic biology

  1. BioConsortia

    BioConsortia develops microbial biological inputs for crops in nitrogen fixation, biocontrol and biostimulants, designed primarily for seed application, using its microbe…

    $15M · 2026-10-15Microbiology & synthetic biologyOther regions

  2. K-Bio Gateway

    Develops 'diet probiotics' and green-bio materials (DH24).

    Seed · KRW 1.2B · 2026-09-21Microbiology & synthetic biologyKorea

  3. Generare

    Molecular data for drug development from microbial genomes.

    €20M · 2026-04-02Microbiology & synthetic biologyEurope

  4. baCta

    Microorganisms as programmable factories for industrial ingredients.

    €7M · 2026-03-03Microbiology & synthetic biologyEurope

  5. ZBiotics

    ZBiotics makes genetically engineered probiotics.

    Y Combinator Winter 2018Microbiology & synthetic biologyNorth America

  6. Reshape Biotech

    Robots that automate the everyday tasks of microbiologists.

    Y Combinator Winter 2021Microbiology & synthetic biologyEurope

All startups in this market →